Painkillers Market - Top Companies and Manufacturers

  • Report ID: 6691
  • Published Date: Nov 14, 2024
  • Report Format: PDF, PPT

Companies Dominating the Painkillers Landscape

    The popularity of complementary therapeutics and medical cannabis are gaining traction in this sector. However, the painkillers market is now shifting towards developing sustainable properties in supplements. This is further changing the dynamics of the industry through offering innovative solutions for effective pain management. For instance, in April 2022, Genexa launched Clean Acetaminophen Pain Relief Products for Adults. The new products are manufactured without using artificial dyes, fillers, and preservatives, making the series a first-of-its-kind alternative solution for pain management. These innovations are propelling the market to grow higher in the upcoming years. Such key players include:

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Johnson & Johnson
    • Novartis AG
    • GlaxoSmithKline plc
    • Bayer AG
    • Eli Lilly and Company
    • Sanofi S.A.
    • Merck & Co., Inc.
    • AstraZeneca plc
    • Teva Pharmaceutical Industries Ltd.
    • Vertex Pharmaceuticals Inc.
    • Latigo Bio

Browse Key Market Insights with Data Illustration:

In the News

  • In April 2024, Vertex approved the rolling for Suzetrigine in moderate-to-severe acute pain. The company is considering the VX-548 approvals as a part of the advancements in the Suzetrigine pain program to serve as a new class of medicine for acute and neuropathic pain.
  • In February 2024, Latigo Bio received USD 135 million in series A financing from Westlake. The grant will be used to develop advanced non-opioid pain medicines, expanding the company’s novel pain therapeutics portfolio.

Author Credits:  Radhika Pawar


  • Report ID: 6691
  • Published Date: Nov 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the painkillers market was over USD 75.7 billion.

The market size for the painkillers market is projected to reach USD 126.9 billion by the end of 2037 expanding at a CAGR of 4.4% during the forecast period i.e., between 2025-2037.

The major players in the market are Pfizer Inc., Johnson & Johnson, Novartis AG, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, Sanofi S.A., Merck & Co., Inc., AstraZeneca plc, Teva Pharmaceutical Industries Ltd., and others.

In terms of product, the OTC products segment is anticipated to garner the largest market share of 52.7% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 45.9% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample